Aztreonam is a Monobactam Antibacterial. Aztreonam is a parenterally administered, synthetic monobactam antibiotic that is specifically active against aerobic gram-negative bacilli is resistant to many beta-lactamases. Aztreonam therapy is often accompanied by mild, asymptomatic elevations in serum aminotransferase levels, but it has not been reported to cause clinically apparent liver injury. It is grouped under the following drug class(es): Beta-lactams. Its therapeutic use is listed as anti-infectives, antibacterials and antibiotics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Primbactam, Nebactam and Cayston. Its PubChem CID is 5742832.
Aztreonam
| CAS No | 78110-38-0 |
|---|---|
| Molecular Formula | C13H17N5O8S2 |
| Molecular Weight | 435.43 g/mol |
| Synonyms | 2-[(Z)-[1-(2-amino-1,3-thiazol-4-yl)-2-[[(2S,3S)-2-methyl-4-oxo-1-sulfoazetidin-3-yl]amino]-2-oxoethylidene]amino]oxy-2-methylpropanoic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Aztreonam is a Monobactam Antibacterial. Aztreonam is a parenterally administered, synthetic monobactam antibiotic that is specifically active against aerobic gram-negative bacilli is resistant to many beta-lactamases.
The listed CAS number is 78110-38-0.
The listed molecular formula is C13H17N5O8S2.
The listed molecular weight is 435.43 g/mol.
2-[(Z)-[1-(2-amino-1,3-thiazol-4-yl)-2-[[(2S,3S)-2-methyl-4-oxo-1-sulfoazetidin-3-yl]amino]-2-oxoethylidene]amino]oxy-2-methylpropanoic acid.
The source lists Primbactam, Nebactam and Cayston.